LUCD
Price
$1.17
Change
-$0.02 (-1.68%)
Updated
Jun 27 closing price
Capitalization
42.94M
50 days until earnings call
NXL
Price
$0.92
Change
-$0.08 (-8.00%)
Updated
Jun 27 closing price
Capitalization
13.84M
66 days until earnings call
Interact to see
Advertisement

LUCD vs NXL

Header iconLUCD vs NXL Comparison
Open Charts LUCD vs NXLBanner chart's image
Lucid Diagnostics
Price$1.17
Change-$0.02 (-1.68%)
Volume$9.85M
Capitalization42.94M
Nexalin Technology
Price$0.92
Change-$0.08 (-8.00%)
Volume$129K
Capitalization13.84M
LUCD vs NXL Comparison Chart in %
Loading...
LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LUCD vs. NXL commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LUCD is a Buy and NXL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (LUCD: $1.17 vs. NXL: $0.92)
Brand notoriety: LUCD and NXL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LUCD: 778% vs. NXL: 130%
Market capitalization -- LUCD: $42.94M vs. NXL: $13.84M
LUCD [@Medical Specialties] is valued at $42.94M. NXL’s [@Medical Specialties] market capitalization is $13.84M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LUCD’s FA Score shows that 0 FA rating(s) are green whileNXL’s FA Score has 0 green FA rating(s).

  • LUCD’s FA Score: 0 green, 5 red.
  • NXL’s FA Score: 0 green, 5 red.
According to our system of comparison, NXL is a better buy in the long-term than LUCD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LUCD’s TA Score shows that 3 TA indicator(s) are bullish while NXL’s TA Score has 4 bullish TA indicator(s).

  • LUCD’s TA Score: 3 bullish, 7 bearish.
  • NXL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NXL is a better buy in the short-term than LUCD.

Price Growth

LUCD (@Medical Specialties) experienced а -7.14% price change this week, while NXL (@Medical Specialties) price change was -11.54% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +1.35%, and the average quarterly price growth was -0.23%.

Reported Earning Dates

LUCD is expected to report earnings on Aug 18, 2025.

NXL is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Medical Specialties (+1.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LUCD($42.9M) has a higher market cap than NXL($13.8M). LUCD YTD gains are higher at: 42.909 vs. NXL (-66.667). NXL has higher annual earnings (EBITDA): -4.56M vs. LUCD (-49.75M). LUCD has more cash in the bank: 18.9M vs. NXL (3.94M). NXL has less debt than LUCD: NXL (518K) vs LUCD (15.3M). LUCD has higher revenues than NXL: LUCD (2.43M) vs NXL (129K).
LUCDNXLLUCD / NXL
Capitalization42.9M13.8M311%
EBITDA-49.75M-4.56M1,091%
Gain YTD42.909-66.667-64%
P/E RatioN/AN/A-
Revenue2.43M129K1,882%
Total Cash18.9M3.94M480%
Total Debt15.3M518K2,954%
TECHNICAL ANALYSIS
Technical Analysis
LUCDNXL
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 21 days ago
81%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 13 days ago
83%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HAO1.300.04
+3.17%
Haoxi Health Technology Limited
TME19.100.40
+2.14%
Tencent Music Entertainment Group
RDWR29.170.04
+0.14%
Radware Ltd
LITE94.750.04
+0.04%
Lumentum Holdings
PAVS0.84N/A
N/A
Paranovus Entertainment Technology Ltd

LUCD and

Correlation & Price change

A.I.dvisor tells us that LUCD and NOTV have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and NOTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
-1.68%
NOTV - LUCD
33%
Poorly correlated
-7.61%
FEMY - LUCD
30%
Poorly correlated
-0.33%
INGN - LUCD
26%
Poorly correlated
-1.60%
CRL - LUCD
26%
Poorly correlated
-1.04%
BWAY - LUCD
25%
Poorly correlated
+0.92%
More

NXL and

Correlation & Price change

A.I.dvisor tells us that NXL and HYPR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NXL and HYPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXL
1D Price
Change %
NXL100%
-8.00%
HYPR - NXL
24%
Poorly correlated
N/A
BFLY - NXL
24%
Poorly correlated
-2.97%
OFIX - NXL
22%
Poorly correlated
+0.45%
LUCD - NXL
21%
Poorly correlated
-1.68%
SAFLY - NXL
21%
Poorly correlated
N/A
More